適應症
亞培肝炎HCV病毒負荷量檢驗套組為一體外檢驗方法,以反轉錄聚合酶連鎖反應RT-PCR的方式定量感染病患的血清或血漿檢體中C型肝炎病毒之核醣核甘酸 (HCV RNA) 。Abbott的設計是用以幫助正在進行抗病毒藥劑治療的HCV患者之追蹤。其檢驗方法非用於提供者之血液、血漿、血清或組織之HCV病毒篩檢或是作為確認HCV感染的診斷依據。  
劑型
 
包裝
# 4J86-70 、# 4J86-80、# 4J86-90 
許可證字號
衛部藥製字第018956號 
註銷狀態
註銷日期
 
註銷理由
 
有效日期
2028-02-18  
發證日期
2008-02-18  
許可證種類
09 
中文品名
亞培C型肝炎病毒負荷量檢驗套組 
英文品名
Abbott RealTime TM HCV 
藥品類別
B 血液學及病理學裝置 
申請商地址
臺北市中山區民生東路3段49號5樓、6樓及51號6樓 
通關簽審文件編號
DHA00601895604 
資料更新時間
 
製造商
名稱 廠址 公司地址 國別 製程
ABBOTT MOLECULAR INC. 1300 EAST TOUHY AVENUE, DES PLAINES, IL 60018, USA US
成份表
處方標示 成分名稱 含量 單位
1 # 4J86-90:Abbott RealTime HCV Amplification Reagent Kit\n?Abbott RealTime HCV Internal Control :<0.01% noninfectious Armored RNA with internal control sequences in negative human plasma. Negative human plasma tested and found to be nonreactive for HBsAg, HBV DNA, HCV RNA, HIV RNA, anti-HIV-1/HIV-2, and anti-HCV. \n?Abbott RealTime HCV Amplification Reagent Pack:1 bottle (0.141 mL) Thermostable rTth Polymerase Enzyme (2.9 to 3.5 Units/μL) in buffered solution, 1 bottle (1.10 mL) HCV Oligonucleotide Reagent. <0.1% synthetic oligonucleotides (4 primers, 2 probes), and <0.3% dNTPs in a buffered solution with a reference dye, 1 bottle (0.40 mL) Activation Reagent. 30mM manganese chloride solution.
1 # 4J86-80:Abbott RealTime HCV Control Kit\n?Abbott RealTime HCV Negative Control:Negative human plasma tested and found to be nonreactive for HBsAg HBV DNA, HCV RNA, HIV RNA, anti-HIV-1/HIV-2, and anti-HCV. \n?Abbott RealTime HCV Low Positive Contorl and Abbott RealTime HCV High Positive Control:Noninfectious Armored RNA with HCV sequences in negative human plasma. Negative human plasma tested and found to be nonreactive for HBsAg, HBV DNA, HCV RNA, HIV RNA, anti-HIV-1/HIV-2, and anti-HCV.
1 # 4J86-70:Abbott RealTime HCV Calibrator Kit\n? Abbott RealTime HCV Calibrator A and Abbott RealTime HCV Calibrator B:\nNoninfectious Armored RNA with HCV sequences in negative human plasma. Negative human plasma tested and found to be nonreative for HBsAg, HBV DNA, HCV RNA, HIV RNA, anti-HIV-1/HIV-2, and anti-HCV.